View Document Preview and Link
Open Document Share Result on Facebook
City South San Francisco / Washington DC / San Diego / / Company Fleming / Genentech / IDEC Pharmaceuticals / / Country United States / / / Event Patent Filing / / Facility University of Hong Kong / University Department / The University of Hong Kong / Queen Mary Hospital / / IndustryTerm treatment of relapsed acute promyelocytic leukemia / treatment of leukemia / treatment of acute promyelocytic leukemia / therapy for relapsed indolent lymphoma / / MedicalCondition severe CD4 lymphopenia / ventricular tachycardia / Headache / chronic renal failure / cerebral hemorrhage / B19 infection / Leukocytosis / acute promyelocytic leukemia / alemtuzumab-induced pure red cell aplasia / relapsed acute promyelocytic leukaemia / MS / relapsed acute promyelocytic leukemia / arrhythmia / leukemia / opportunistic infections / Cardiac arrhythmias / parvovirus B19 infection / relapsed-acute promyelocytic leukemia / retinoic acid syndrome / diabetes mellitus / acute promyelocytic leukaemia recurring / relapsed indolent lymphoma / lymphoproliferative diseases / chronic rheumatic heart disease / acute myeloid leukemia / Pure red-cell aplasia / Pure red cell aplasia / / MedicalTreatment continuous ambulatory peritoneal dialysis / CAPD / antibody therapy / remission induction / / Organization University Department of Medicine / American Society of Hematology / FDA / University of Hong Kong / Queen Mary Hospital / / Person Yan Au / Cyrus R. Kumana / Todd D. Delicious / Prince / Ching-Wan Lam / Mark C. Benyunes / Liang R. Arsenic / Ida Ida / Godfrey C. F. Chan / Raymond Mak / Ida Dauno / Yok-Lam Kwong Correspondence / Maybelle Kou / Ann Intern / Professorial Block / / Position editor / MP / last Hb / Prince / / Product Rituxan / R2 / R1 / / ProgrammingLanguage DC / / ProvinceOrState Alaska / California / / Technology transplantation / dialysis / / URL http / SocialTag